| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.87B | +28.8% |
| Cost of Revenue | $566.0M | +31.3% |
| Gross Profit | $2.30B | +28.2% |
| R&D Expense | $507.9M | +25.5% |
| SG&A Expense | $593.5M | +13.2% |
| Operating Income | $310.4M | +158.7% |
| Pre-tax Income | $489.2M | +106.3% |
| Income Tax | $21.3M | +7.8% |
| Net Income | $462.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.10B | +152.5% |
| Short-term Investments | $3.13B | +10.1% |
| Accounts Receivable | $575.0M | +57.6% |
| Current Assets | $5.93B | +43.4% |
| Total Assets | $6.34B | +40.2% |
| Current Liabilities | $996.0M | +33.5% |
| Total Liabilities | $1.25B | +29.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.15B | +62.0% |
| Capital Expenditures | $12.6M | -16.4% |
| Investing Cash Flow | -$340.7M | +87.4% |
| Financing Cash Flow | $463.4M | +111.7% |
| Free Cash Flow | $1.14B | +63.7% |
| +120.3% |
| EPS (Basic) | $0.21 | +110.0% |
| EPS (Diluted) | $0.19 | +111.1% |
| Stockholders' Equity |
| $5.00B |
| +44.0% |